A proportion of patients with lymphoma may harbor mutations of the perform gene

Blood

Volumn 105, Issue 11, 2005, Pages 4424-4428

  Clementi, Rita ^a   Locatelli, Franco ^b   Dupré, Loïc ^b   Garaventa, Alberto ^b   Emmi, Lorenzo ^b   Bregni, Marco ^b   Cefalo, Graziella ^b   Moretta, Antonia ^b   Danesino, Cesare ^b   Comis, Margherita ^b   Pession, Andrea ^b   Ramenghi, Ugo ^b   Maccario, Rita ^b   Aricò, Maurizio ^b   Roncarolo, Maria Grazia ^b  

^a Istituto di Genetica Molecolare   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; PERFORIN;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CARCINOGENESIS; CELL SURVIVAL; CHILD; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE MUTATION; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HODGKIN DISEASE; HUMAN; IMMUNOSURVEILLANCE; LYMPHOCYTE; MALE; NATURAL KILLER CELL; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN DEFICIENCY; T CELL LYMPHOMA; TUMOR GROWTH;

EID: 21144435788     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-04-1477     Document Type: Article

References (26)

1. Lichtenheld MG, Olsen KJ, Lu P, et al. Structure and function of human perforin. Nature. 1988;335:448-451.
2. Trapani JA, Smyth MJ. Functional significance of the perforin/granzyme cell death pathway. Nature Rev Immunol. 2002;2:735-747.
3. Trapani JA, Davis J, Sutton VR, Smyth MJ. Proapoptotic functions of cytotoxic lymphocyte granule constituents in vitro and in vivo. Curr Opin Immunol. 2000;12:323-329.
4. Stepp S, Dufourcq-Lagelouse R, Le Deist F, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999;286:1957-1959.
5. Ericson KG, Fadeel B, Nilsson-Ardnor S, et al. Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis. Am J Hum Genet. 2001;68:590-597.
6. Clementi R, zur Stadt U, Savoldi G, et al. Six novel mutations in the PRF1 gene in children with haemophagocytic lymphohistiocytosis. J Med Genet. 2001;38:643-646.
7. Feldmann J, Le Deist F, Ouachee-Chardin M, et al. Functional consequences of perforin gene mutations in 22 patients with familial haemophagocytic lymphohistiocytosis. Br J Haematol. 2002;117:965-972.
8. Arico M, Janka G, Fischer A, et al. Hemophagocytic lymphohistiocytosis: report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. Leukemia. 1996;10:197-203.
9. Farquhar J, Claireaux A. Familial haemophagocytic reticulosis. Arch Dis Child. 1952;27:519-525.
10. Matioubian M, Suresh M, Glass A, et al. A role for perforin in downregulating T-cell responses during chronic viral infection. J Virol. 1999;73:2527-2536.
11. Jordan MB, Hiideman D, Kapler J, Marrack P. An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. Blood. 2004;104:735-743.
12. Smyth MJ, Thia KY, Street SE, MacGregor D, Godfrey DI, Trapani JA. Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J Exp Med. 2000;192:755-760.
13. Montagna D, Maccario R, Ugazio AG, et al. Cell-mediated cytotoxicity in Down-syndrome: impairment of allogeneic mixed lymphocyte reaction, NK and N-like activities. Eur J Pediatr. 1988;148:53-57.
14. Clementi R, Emmi L, Maccario R, et al. Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in siblings carrying PRF1 mutations. Blood. 2002;100:2266-2267.
15. McCormick J, Flower DR, Strobel S, Wallace DL, Beverley PC, Tchilian EZ. Novel perforin mutation in a patient with hemophagocytic lymphohistiocytosis and CD45 abnormal splicing. Am J Med Genet A. 2003;117:255-260.
16. National Center for Biotechnology Information. BLAST: Basic Local Alignment Search Tool. http://www.ncbi.nlm.nih.gov/BLAST/. Accessed March 2003.
17. Clementi R, Dagna L, Dianzani U, et al. Inherited Perforin and Fas mutations in a patient with autoimmune lymphoproliferative syndrome and lymphoma. N Engl J Med. 2004;351:1419-1424.
18. van den Broek ME, Kagi D, Ossendorp F, et al. Decreased tumor surveillance in perforin-deficient mice. J Exp Med. 1996;184:1781-1790.
19. Smyth MJ, Thia KY, Cretney E, et al. Perform is a major contributor to NK cell control of tumor metastasis. J Immunol. 1999;162:6658-6662.
20. Shustov A. Luzina I, Nguyen P, et al. Role of perforin in controlling B-cell hyperactivity and humoral autoimmunity. J Clin Invest. 2000;106:R39-R47.
21. Feldmann J, Menasche G, Callebaut I, et al. Severe and progressive encephalitis as a presenting manifestation of a novel missense perforin mutation and impaired cytolytic activity. Blood. 2004;105:2658-2663.
22. Molleran Lee S, Villanueva J, Sumegi J, et al. Characterization of diverse PRF-1 mutations leading to decreased to natural kilter cell activity in North-American families in haemophagocytic lymphohistiocytosis. J Med Genet. 2004;41:137-144.
23. Voskoboinik I, Thia MC, Trapani JA. A functional analysis of the putative polymorphisms A91V and N252S, and 22 missense perforin mutations associated with familial hemophagocytic lymphohistiocytosis. Blood. Prepublished on March 8, 2005, as DOI 10.1182/blood-2004-12-4935.
24. Muschen M, Rajewsky K, Kronke M, Kuppers R. The origin of CD95-gene mutations in B-cell lymphoma. Trends Immunol. 2002;23:75-80.
25. Holzelova E, Vonarbourg C, Stolzenberg MC, et al. Autoimmune lymphoproliferative syndrome with somatic Fas mutations. N Engl J Med. 2004;351:1409-1418.
26. Puck JM, Straus SE. Somatic mutations: not just for cancer anymore. N Engl J Med. 2004;351:1388-1390.